Skip to content

Clinical trials

Coronavirus Infections trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronavirus Infections Country / region: China Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20192
202017
20214
20223
20235
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status17
Completed13
Recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.5
AstraZeneca3
Qilu Hospital of Shandong University3
Shanghai Public Health Clinical Center3
BioNTech SE2
Ruijin Hospital2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
Third Affiliated Hospital, Sun Yat-Sen University2
Ansun Biopharma, Inc.1
China National Biotec Group Company Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronavirus Infections34
COVID-1914
Pneumonia5
Severe Acute Respiratory Syndrome3
Virus Diseases3
Infections2
Lung Diseases2
Pneumonia, Pneumocystis2
Respiratory Tract Infections2
Coronaviridae Infections1

Trials

Showing 51 to 34 of 34. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.